Biogena Group Invest AG (WBO:BIO) Inventories, Work In Process: €0.00 Mil (As of Jan. 2026)


WBO:BIO Biogena Group Invest AG WBO:BIO
66 GF Score
Price €4.16
GF Value €3.46
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biogena Group Invest AG Inventories, Work In Process?

Biogena Group Invest AG WBO:BIO -0.48% 66 Inventories, Work In Process is €0.00 Mil as of Jan. 2026. GuruFocus rates WBO:BIO with a GF Score™ of 66/100 and a GF Value™ of €3.46 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Biogena Group Invest AG's work in process for the quarter that ended in Jan. 2026 was €0.00 Mil.

Biogena Group Invest AG Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Biogena Group Invest AG's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG Inventories, Work In Process Chart

Biogena Group Invest AG Annual Data
Trend Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Inventories, Work In Process
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biogena Group Invest AG Semi-Annual Data
Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Inventories, Work In Process Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
WBO:BIO
66GF Score
Biogena Group Invest AG WBO:BIO
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogena Group Invest AG Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €0.00 Mil mean?
Biogena Group Invest AG (WBO:BIO) has a Inventories, Work In Process of €0.00 Mil as of Jan. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biogena Group Invest AG and its competitors.
Is Biogena Group Invest AG's Inventories, Work In Process too high?
Biogena Group Invest AG's current Inventories, Work In Process is €0.00 Mil. Overall, Biogena Group Invest AG has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Inventories, Work In Process compare to KHC and GIS?
Biogena Group Invest AG's Inventories, Work In Process of €0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Consumer Packaged Goods company?
A good Inventories, Work In Process depends on the Consumer Packaged Goods industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biogena Group Invest AG and its competitors. Biogena Group Invest AG's current Inventories, Work In Process is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.46, compared to a current price of €4.16 — trading 20.2% above its estimated fair value. The current Inventories, Work In Process is €0.00 Mil. Biogena Group Invest AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Inventories, Work In Process is €0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued. The current stock price of €4.16 is trading 20.2% above its estimated GF Value™ of €3.46. GuruFocus considers Biogena Group Invest AG to be Modestly Overvalued.

Key valuation signals for WBO:BIO:

  • Inventories, Work In Process: €0.00 Mil
  • GF Value™: €3.46 vs. price of €4.16 (20.2% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biogena Group Invest AG Business Description

Address Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
66GF Score

Get the complete analysis for WBO:BIO

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.16
Price
€3.46
GF Value